Clinical Trial Update: Clinical Study of Intermittent Positive Pressure Breathing (IPPB) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intermittent positive pressure breathing (IPPB) for lung diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases, Lung Diseases, Obstructive | Phase 3 | Status: COMPLETED